CTOR Citius Oncology: Company Short-Term Debts

Symbol and logo of brand Citius Oncology, Inc. (CTOR)

The market dynamics of Citius Oncology, Inc. (CTOR) reflected in the price action help assess the business's debt load, which currently stands at 0.00. The company focuses on oncology, yet military conflicts and sanctions are undermining biomaterial logistics and clinical trials. Strict FDA oversight and patent protection for unique molecules ensure position stability, creating a significant barrier to entry for new players.

CTOR Citius Oncology Inc. Company Short-Term Loans and Borrowings (08/14/2024 - 10/31/2026)

CTOR (Citius Oncology Inc): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Citius Oncology|CTOR - Consensus Target
- company stock capitalization data:
Market Capitalization Citius Oncology, Inc.|CTOR - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Citius Oncology|CTOR - Accounting Value of Company|Market Cap to Net Assets Ratio citiusonc.com|CTOR - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Citius Oncology, Inc.|CTOR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Citius Oncology, Inc.|CTOR - Company Aggregate Debts|Debt to Book Capitalization Ratio Citius Oncology, Inc.|CTOR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Citius Oncology|Quick Ratio citiusonc.com
- earnings and multiples data:
CTOR - Net Income
Analysis of all company metrics:CTOR - Citius Oncology
Manufactured products of citiusonc.com

Citius Oncology, Inc. (CTOR) focuses on developing exclusive immunotoxins, ensuring stable demand and predictable cash flow. This metric aggregates all credit obligations with a maturity of up to one year. A reduction in payment amounts eases the financial burden, whereas a sharp decline may signal a reduction in credit limits. By analyzing the volatility of short-term debt, an investor assesses the biotech's liquidity. This price action reflects the actual speed of debt servicing.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts HURA|Company Current Liabilities protaratx.com TARA|Company Short-Term Debts FATE (Fate Therapeutics)|Short-Term Debt Volume Aadi Bioscience, Inc. (WHWK)|TCRX: Company Current Liabilities|Champions Oncology - Amount of Current Liabilities|XBIT: Company Short-Term Debts|CVM - Short-Term Debt Volume|Company Current Liabilities OSTX|Company Short-Term Debts Radiopharm Theranostics Ltd|Company Short-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|Short-Term Debt Volume adlainortye.com|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|XLO - Company Short-Term Debt|Short-Term Debt Renovaro Inc.|muraloncology.com (MURA) - Company Short-Term Debt|Company Short-Term Indebtedness KAPA|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Company Current Liabilities CytoMed (GDTC)|Company Short-Term Debt Curis, Inc. (CRIS)|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|Advanced Biomed Inc. - Company Short-Term Debt|GNPX - Company Short-Term Debt|Short-Term Debt Calidi Biotherapeutics|SBFM: Company Short-Term Debts|Short-Term Indebtedness Xenetic Biosciences, Inc. XBIO|Company Current Liabilities SLRX|Short-Term Debt Kitov Pharma PPBT|Company Current Liabilities AONC (American Oncology Network)|BGNE (beigene.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Short-Term Debt Volume Elevation Oncology Inc. (ELEV)|ICAD - Company Short-Term Debt|IKNA (Ikena Oncology, Inc.) - Company Short-Term Indebtedness|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Current Liabilities MOR|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debts AAPGV